Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Tax Provisions (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Tax Provisions for 16 consecutive years, with $23245.0 as the latest value for Q4 2025.

  • Quarterly Tax Provisions rose 142.79% to $23245.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $40256.0 through Dec 2025, up 301.28% year-over-year, with the annual reading at $40256.0 for FY2025, 301.28% up from the prior year.
  • Tax Provisions hit $23245.0 in Q4 2025 for Cumberland Pharmaceuticals, up from $5670.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $48150.0 in Q4 2022 to a low of -$54327.0 in Q4 2024.
  • Historically, Tax Provisions has averaged $8488.3 across 5 years, with a median of $7198.0 in 2021.
  • Biggest five-year swings in Tax Provisions: surged 284.71% in 2022 and later plummeted 317.69% in 2024.
  • Year by year, Tax Provisions stood at $12516.0 in 2021, then soared by 284.71% to $48150.0 in 2022, then crashed by 48.17% to $24956.0 in 2023, then tumbled by 317.69% to -$54327.0 in 2024, then skyrocketed by 142.79% to $23245.0 in 2025.
  • Business Quant data shows Tax Provisions for CPIX at $23245.0 in Q4 2025, $5670.0 in Q3 2025, and $5671.0 in Q2 2025.